According to a new market report published by Lucintel, the future of the injectable drug delivery market looks promising with opportunities in the hospitals, clinics, and home care. The injectable drug delivery market is expected to grow with a CAGR of 11% from 2019 to 2024. The major drivers for this market are rising prevalence of chronic diseases, increase in demand for self-injection devices, growth in the biologics market, and technological advancements.
In this market, devices and formulations are the major product segment. Formulation segment is further segmented into novel drug delivery formulations and conventional drug delivery formulations. The device segment is sub-segmented into self injection devices and conventional injection devices. On the basis of comprehensive research, Lucintel forecasts that the formulation is expected to witness highest growth over the forecast period due to growing prevalence of chronic diseases, patient adherence, and the rising adoption of self-injection, new technologies, and biologics.
Within this industry, autoimmune diseases, hormonal disorders, orphan diseases and cancer are the major applications of the injectable drug delivery market. Cancer segment is expected to witness highest growth in the forecast period.
North America will remain the largest market over the forecast period due to increasing prevalence of chronic diseases, growing adoption of self-injectable devices, and rising FDA approvals.
Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, Schott, Eli Lilly and Company, and Terumo are among the major manufacturers of injectable drug delivery market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the injectable drug delivery market by product type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and region. Lucintel has prepared a comprehensive research report entitled "Injectable Drug Delivery Market 2019-2024: Trends, Forecast, and Opportunity Analysis" This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the injectable drug delivery market by product type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and region as follows:
By Product Type [$M shipment analysis for 2013 – 2024]:
• Devices
• Formulations
By Formulation Packaging [$M shipment analysis for 2013 – 2024]:
• Ampules
• Vials
• Cartridges
• Bottles
By Therapeutic Application [$M shipment analysis for 2013 – 2024]:
• Auto-immune diseases
• Hormonal Disorders
• Orphan Diseases
• Oncology
• Others
By Usage Pattern [$M shipment analysis for 2013 – 2024]:
• Curative Care
• Immunization
• Other Usage Pattern
By Site of Administration [$M shipment analysis for 2013 – 2024]:
• Skin
• Circulatory/Musculoskeletal
• Organs
• Central Nervous System
By Distribution Channel [$M shipment analysis for 2013 – 2024]:
• Hospitals
• Retail Pharmacy Stores
By Facility of Use [$M shipment analysis for 2013 – 2024]:
• Hospitals and Clinics
• Home Care Settings
• Other Facilities of Use
By Region [$M shipment analysis for 2013 – 2024]:
• North America
o United States
o Canada
o Mexico
• Europe
o United kingdom
o Germany
o France
o Italy
o Spain
• Asia-Pacific
o China
o India
o Japan
• Rest of the World (ROW)
o Brazil

This research report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:

Q.1. What are some of the most promising potential, high-growth opportunities for the injectable drug delivery market by product type (devices and formulations), by formulation (ampules, vials, cartridges, and bottles),therapeutic application ( auto-immune diseases, hormonal disorders, orphan diseases, oncology and others), usage pattern (curative care, immunization and others), site of administration (skin, circulatory/ musculoskeletal, organs, and central nervous system), distribution channel (hospitals, and retail pharmacy stores), facility of use (hospitals & clinics, and home care settings), and region (North America, Europe, Asia-Pacific, and Rest of the World (ROW))?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the injectable drug delivery market?
Q.5. What are the business risks and threats to the injectable drug delivery market?
Q.6. What are emerging trends in this injectable drug delivery market and the reasons behind them?
Q.7. What are some changing demands of customers in the injectable drug delivery market?
Q.8. What are the new developments in the injectable drug delivery market? Which companies are leading these developments?
Q.9. Who are the major players in this injectable drug delivery market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this injectable drug delivery area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in this injectable drug delivery market?